IOLite: Multipart, phase 1b, dose-finding study of the PD-1 inhibitor dostarlima

Discussion Board › Forums › Clinical Trials › IOLite: Multipart, phase 1b, dose-finding study of the PD-1 inhibitor dostarlima

Viewing 1 post (of 1 total)
  • Author
    Posts
  • May 15, 2019 at 3:31 pm #98608
    gavin
    Moderator

    IOLite: Multipart, phase 1b, dose-finding study of the PD-1 inhibitor dostarlimab in combination with the PARP inhibitor niraparib ± bevacizumab (bev), or with platinum-based chemotherapy ± bev for advanced cancer

    http://abstracts.asco.org/239/AbstView_239_254415.html

  • Author
    Posts
Viewing 1 post (of 1 total)
  • The forum ‘Clinical Trials’ is closed to new topics and replies.